AXOSIM

In News

Organoids touted as future of brain disorder R&D as AxoSim scoops up tech from Vyant subsidiary - Fierce Biotech

Fierce Biotech - Oct 24, 2023

AxoSim acquires microBrain technology to build neurological drug pipeline - Pharmaceutical Technology

Pharmaceutical Technology - Oct 25, 2023

New Orleans biotech firm AxoSim hires new CEO ahead of major fund raising - NOLA.com

NOLA.com - Jun 11, 2024

AxoSim Acquires Vyant Bio’s StemoniX Assets for $2.25M - Contract Pharma

Contract Pharma - Jul 17, 2023

2 Biotech Industry Vets to Lead AxoSim Board - Biz New Orleans

Biz New Orleans - Mar 06, 2024

AxoSim touts results of nerve-on-a-chip study - Drug Delivery Business

Drug Delivery Business - Jul 09, 2019

2023 Achievements Marked by New Technologies, Commercialization and Advanced Research - Louisiana Economic Development (.gov)

Louisiana Economic Development (.gov) - Jan 03, 2024

Engineering a 3D functional human peripheral nerve in vitro using the Nerve-on-a-Chip platform - Nature

Nature - Jun 20, 2019

Scientists Recreate Human Peripheral Nerve Cells’ Interactions on a Chip - ALS News Today

ALS News Today - Jul 12, 2019

Vyant Bio enters into deal to sells its microBrain assets for $2.25M - The Business Journals

The Business Journals - Jul 17, 2023

AxoSim grows from 'two guys in a broom closet at Tulane' to biotech darling - NOLA.com

NOLA.com - Mar 17, 2023

New Orleans Life Science Company Names New CEO - Biz New Orleans

Biz New Orleans - Jun 11, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment